Successful treatment of metastatic colorectal cancer with synchronous BRAF V600E mutation and dMMR with BGB-A317

Cheng, Y; Fang, XF; Hu, HG; Wang, J; Sun, LF; Yuan, Y

Yuan, Y (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Med Oncol, Hangzhou 310009, Zhejiang, Peoples R China.; Yuan, Y (corresponding author), Zhejiang Univ, Sch Med, Chinese Natl Minist Educ, Canc Inst,Key Lab Canc Prevent & Intervent, Hangzhou 310009, Zhejiang, Peoples R China.; Yuan, Y (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Key Lab Mol Biol Med Sci, Hangzhou 310009, Zhejiang, Peoples R China.

IMMUNOTHERAPY, 2020; 12 (4): 229

Abstract

Metastatic colorectal cancer with BRAF mutation is a type of highly invasive malignant tumor with poor prognosis and few treatment options. Here, we r......

Full Text Link